Who owns SENTI BIOSCIENCES ORD?
- Ticker: SNTI
- CUSIP Number: 81726a100
Tip: Access positions for across all investors
Analyze quarterly positions in Senti Biosciences Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Senti Biosciences Ord stock
Who bought or sold SENTI BIOSCIENCES ORD this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
NEA Management Company | 4.4M | $2.9M | 0% | Dec 2023 |
|
8vc Gp I | 2.5M | $1.7M | 100% | Dec 2023 |
|
ARK Investment Management | 1.6M | $615k | -17% | Mar 2024 |
|
Vanguard Group | 707k | $467k | 28% | Dec 2023 |
|
Intel Corporation | 596k | $393k | 0% | Dec 2023 |
|
Omega Fund Management | 196k | $129k | 0% | Dec 2023 |
|
Artal Group | 56k | $37k | 0% | Dec 2023 |
|
Citadel Advisors | 44k | $29k | 100% | Dec 2023 |
|
Two Sigma Investments | 29k | $19k | 100% | Dec 2023 |
|
Harbour Investments | 15k | $9.9k | 50% | Dec 2023 |
|
Millennium Management | 14k | $9.5k | 100% | Dec 2023 |
|
Bank of New York Mellon | 12k | $8.2k | 0% | Dec 2023 |
|
Bank of America Corporation | 5.2k | $3.4k | -83% | Dec 2023 |
|
Wolverine Asset Management | 800.00 | $528.000000 | 0% | Dec 2023 |
|
Wells Fargo & Company | 199.00 | $131.001700 | 5% | Dec 2023 |
|
Jpmorgan Chase & Co | 43.00 | $28.001600 | 34% | Dec 2023 |
|
Who sold out of Senti Biosciences Ord?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
T. Rowe Price Associates | Sep 2023 | 3.1M | $1.3M |
TD Asset Management | Sep 2023 | 241k | $102k |
Royal Bank of Canada | Sep 2023 | 496.00 | $0 |
UBS Group | Sep 2023 | 202.00 | $83.001800 |